Latest Mesa Royalty Trust (MTR) Headlines Shares of MTR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Mesa Royalty Trust (MTR) Headlines

Shares of MTR Up 12.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Mar 11, 9:15AM CDT
SmarTrend identified an Uptrend for Mesa Royalty Trust (NYSE:MTR) on December 26th, 2013 at $22.00. In approximately 3 months, Mesa Royalty Trust has returned 12.73% as of today's recent price of $24.80.

Mesa Royalty Trust Announces Trust Income for February 2014
Business Wire - Tue Feb 18, 2:30PM CST
Mesa Royalty Trust (NYSE: MTR) announced the Trust income distribution for the month of February 2014. Unitholders of record on February 28, 2014 will receive distributions amounting to $0.205531264 per unit payable on April 30, 2014. The Trust received $239,222 and $28,003 from the New Mexico and Colorado portions of the San Juan Basin Properties. Royalty income from the Hugoton Properties totaled $122,550.

NYSE stocks posting largest volume decreases
AP - Fri Feb 14, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on New York Stock Exchange at the close of trading:

Results-Based Approach Spurs Development
All Africa Global Media - Tue Jan 21, 3:40AM CST
As should be known by every Zimbabwean by now, Zim-Asset is Government's economic blueprint for 2013 to 2018.

Mesa Royalty Trust declares distribution of USD0.180521377 per unit for January 2014
M2 - Mon Jan 20, 8:11AM CST
Mesa Royalty Trust (NYSE:MTR), a holder of net overriding royalty interests in oil and gas producing properties, on Friday declared the Trust income distribution of USD0.180521377 per unit, for January 2014.

Mesa Royalty Trust Announces Trust Income for January 2014
Business Wire - Fri Jan 17, 1:00PM CST
Mesa Royalty Trust (NYSE:MTR) announced the Trust income distribution for the month of January 2014. Unitholders of record on January 31, 2014 will receive distributions amounting to $0.180521377 per unit payable on April 30, 2014. The Trust received $218,764 and $1,854 from the New Mexico and Colorado portions of the San Juan Basin Properties. Royalty income from the Hugoton Properties totaled $146,839.

NYSE stocks posting largest percentage decreases
AP - Mon Dec 30, 12:40PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:

Mesa Royalty Trust Announces Trust Income for December 2013
Business Wire - Wed Dec 18, 11:30AM CST
Mesa Royalty Trust (NYSE: MTR) announced the Trust income distribution for the month of December 2013. Unitholders of record on December 31, 2013 will receive distributions amounting to $0.196057029 per unit payable on January 31, 2014. The Trust received $229,422 and $28,334 from the New Mexico and Colorado portions of the San Juan Basin Properties. Royalty income from the Hugoton Properties totaled $121,414.

Mesa Royalty Trust Announces Trust Income for November 2013
Business Wire - Tue Nov 19, 11:30AM CST
Mesa Royalty Trust (NYSE: MTR) announced the Trust income distribution for the month of November 2013. Unitholders of record on November 29, 2013 will receive distributions amounting to $0.156880656 per unit payable on January 31, 2014. The Trust received $243,026 and $29,144 from the New Mexico and Colorado portions of the San Juan Basin Properties. Royalty income from the Hugoton Properties totaled $31,887.

Mesa Royalty Trust Announces Trust Income for October 2013
Business Wire - Thu Oct 17, 1:30PM CDT
Mesa Royalty Trust (NYSE: MTR) announced the Trust income distribution for the month of October 2013. Unitholders of record on October 31, 2013 will receive distributions amounting to $0.151064484 per unit payable on January 31, 2014. The Trust received $233,628 and $31,392 from the New Mexico and Colorado portions of the San Juan Basin Properties. Royalty income from the Hugoton Properties totaled $30,690.

Mesa Royalty Trust declares trust income for September 2013 of USD0.138449251 per unit
M2 - Fri Sep 20, 8:25AM CDT
Mesa Royalty Trust (NYSE:MTR), a holder of net overriding royalty interests in US oil and gas producing properties, on Thursday declared its income distribution of USD0.138449251 per unit for September 2013.

Mesa Royalty Trust Announces Trust Income for September 2013
Business Wire - Thu Sep 19, 3:36PM CDT
Mesa Royalty Trust (NYSE:MTR) announced the Trust income distribution for the month of September 2013. Unitholders of record on September 30, 2013 will receive distributions amounting to $ 0.138449251 per unit payable on October 31, 2013. The Trust received $213,234 and $33,159 from the New Mexico and Colorado portions of the San Juan Basin Properties. Royalty income from the Hugoton Properties totaled $12,811.

Mesa Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013
M2 - Fri Sep 13, 2:51AM CDT
Summary

Mesa Royalty Trust Announces Trust Income for August 2013
Business Wire - Mon Aug 19, 2:00PM CDT
Mesa Royalty Trust (NYSE: MTR) announced the Trust income distribution for the month of August 2013. Unitholders of record on August 30, 2013 will receive distributions amounting to $ 0.229370350 per unit payable on October 31, 2013. The Trust received $166,635 and $156,492 from the New Mexico and Colorado portions of the San Juan Basin Properties. Royalty income from the Hugoton Properties totaled $120,116.

CRWEFINANCE Daily Stock Watch Community Bankers Trust Corporation (NASDAQ:ESXB), Crown Equity Holdings Inc. (OTCQB:CRWE), and Mesa Royalty Trust (NYSE:MTR)
WorldStockWire - Tue Jul 30, 11:00AM CDT
CRWEfinance.com, a division of Crown Equity Holdings Inc. (OTCQB:CRWE) tracks stocks daily and is pleased to offer its hot stock to watch . Our stock focus today is on:

Mesa Royalty Trust (MTR) Stock Research Links

MTR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 8

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 13

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 14

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 10

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 6

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Merus N.V. Receives Buy Rating from UBS Focusing on Cancer Treatments

Updated Category News Views 87

UBS Initiates Coverage on Merus N.V. UBS has begun coverage on Merus N.V. (NASDAQ: MRUS) with a positive outlook, assigning a Buy rating and setting a price target of $72.00. This decision is backed by the firm's confidence in Merus's leading therapeutic candidate, petosemtamab, recognized for its potential in treating head and neck cancer. Anticipated Breakthroughs with...

Continue Reading
Exploring the Investment Landscape of Caterpillar Options Activity

Updated Category News Views 37

Investing Insights into Caterpillar's Options Activity Recently, substantial movements have been observed in the options market for Caterpillar, particularly from notable financial organizations. Our examination reveals that Caterpillar (NYSE: CAT) has experienced 35 unusual trades within its options history, indicating heightened interest among traders. Analyzing Trader...

Continue Reading
Exploring the Expanding Portable Ultrasound Market Trends

Updated Category News Views 114

Understanding the Portable Ultrasound Market The Portable Ultrasound Market has been experiencing a remarkable transformation, projected to reach a significant valuation of US$3.84 billion by the end of the period. The growth rate is expected to maintain a strong compound annual growth rate (CAGR) of 9.0%. Major factors contributing to this expansion include the rising...

Continue Reading
Impressive Growth: $1000 Investment in Primoris Services Today

Updated Category News Views 147

Exploring the Growth of Primoris Services Stock Over the past 15 years, Primoris Services (NYSE: PRIM) has demonstrated impressive performance, significantly surpassing the average market returns. With an annualized return of 19.13%, it has outperformed the market by 7.08%. Such performance exemplifies how strategic investment in a solid company can yield substantial...

Continue Reading
Cellebrite Releases Its Annual Report for 2024, Highlights Key Insights

Updated Category News Views 408

Cellebrite Completes Filing of 2024 Annual Report Cellebrite, a renowned name in digital investigative solutions, has officially filed its Annual Report on Form 20-F for the fiscal year ending on December 31, 2024. This significant move marks another step in the company’s commitment to transparency and accountability, aligning with its mission to facilitate justice and...

Continue Reading